Bills Supporting Device Opioid Alternatives Advance In House

The House Energy and Commerce Committee approved four opioid crisis-related bills that call for US FDA meetings and consideration of streamlined pathways for medtech alternatives to opioids, and for a report and action by the US Medicare agency on overcoming payment challenges to device pain control products.

Four bills cleared by the House E & C Committee Thursday would address ways to overcome barriers to faster approval by FDA and reimbursement by the Centers for Medicare and Medicaid Services for device alternatives to opioids to control pain and treat addictions.

The device industry has taken note that medtech products to treat pain and help manage opioid addictions have not received...

More from Legislation

More from Policy & Regulation